Study identifier:D822EC00001
ClinicalTrials.gov identifier:NCT05665374
EudraCT identifier:N/A
CTIS identifier:N/A
General Use-Results Study of Calquence capsules 100 mg in Patients with Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)
Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)
N/A
No
-
All
50
Observational
n/a - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Sept 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|